Abstract Library

#2959 Synergic Value of 68Ga-DOTATOC PET and MRI in NET Patients Undergoing Simultaneous 68Ga-DOTATOC PET/MRI Scan

Introduction: The simultaneous acquisition of 68Ga-DOTATOC PET and functional MRI has relevant implication in the field of Neuroendocrine Tumours (NETs).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Mapelli P, Ironi G, Partelli S, Andreasi V, Muffatti F,

Keywords: 68Ga-DOTATOC, PET/MRI, NET, staging, restaging,

#2938 Rectal Neuroendocrine Tumor with Concomitant Erdheim-Chester Disease: A Rare Case Report

Introduction: Rectal neuroendocrine tumor (NET), a type of rare tumor, is rather rarer when accompanied by non-Langerhans cells histiocytosis named Erdheim-Chester disease (ECD).

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Zhang Y, Liu M, Chen L, Guo Y, Chen M,

Keywords: rectal neuroendocrine tumor, Erdheim-Chester disease.,

#2787 64Cu-DOTATATE PET/CT Imaging of Patients with Neuroendocrine Neoplasms Can Be Performed between 1 and 3 Hours after Radiotracer Injection: Comparison of Lesion Detection Ability and Contrast

Introduction: PET/CT imaging of patients with neuroendocrine neoplasms (NEN) 1 hour (h) post injection (pi) of 64Cu-DOTATATE has shown superiority in lesion detection when compared to other clinically available somatostatin receptor imaging (SRI) modalities.

Conference: 17th Annual ENETSConcerence (2020)

Presenting Author:

Authors: Loft M, Johannesen H, Carlsen E, Johnbeck C, Binderup T,

Keywords: 64Cu-DOTATATE, Neuroendocrine Neoplasms, PET Imaging, Somatostatin Receptor Imaging,

#2206 Metastatic Neuroendocrine Tumor with Unknown Primary Site Presenting Simultaneously with Prostate Adenocarcinoma

Introduction: Neuroendocrine tumors (NET) arise from a variety of different organs and have a steadily increasing incidence in the last 3 decades. 13% of NETs have unknown primary sites.

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author:

Authors: Enache O, Martin S, Lambrescu I, Sirbu A, Constantin T,

Keywords: neuroendocrine, somatostatin analogs,

#1519 Gastric Type I Neuroendocrine Tumors Endoscopic Treatment Options

Introduction: From 1998 till 2014 in our institution we have identified 72 patients with type I gastric neuroendocrine tumors (NET), 42 of them, without regional or distant metastases, undergone different types of endoscopic treatment.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Sokolov V, Pirogov S, Karpova E, Pavlov P, Sokolov D,

Keywords: gastric, NET, endoscopic, EMR, ESD, APC,